10x Genomics (TXG) Net Equity Issued and Repurchased (2019 - 2020)
10x Genomics' (TXG) quarterly Net Equity Issued and Repurchased came in at -$780000.0 in Q4 2020, up 57.95% year-over-year from -$493822.5 in Q1 2020, and up 57.95% quarter-over-quarter from -$1.9 million in Q4 2019.
Powered by 
Analysis
10x Genomics (TXG) Net Equity Issued and Repurchased (2019 - 2020) Analysis & Trends
10x Genomics has disclosed Net Equity Issued and Repurchased across 2 years of filings, most recently posting -$780000.0 for Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 226.93 Bn | 222.99 Bn | 8.34 Bn | - |
| 2 | Danaher | 145.94 Bn | 141.60 Bn | 3.61 Bn | - |
| 3 | Agilent Technologies | 42.55 Bn | 40.79 Bn | 1.04 Bn | - |
| 4 | Illumina | 32.95 Bn | 31.78 Bn | 770.00 Mn | - |
| 5 | Revvity | 14.53 Bn | 13.51 Bn | 416.87 Mn | - |
| 6 | Bio-Techne | 11.31 Bn | 11.04 Bn | 211.39 Mn | - |
| 7 | Bio-Rad Laboratories | 10.34 Bn | 8.72 Bn | 345.80 Mn | 4.20 Mn |
| 8 | Repligen | 9.46 Bn | 8.44 Bn | 110.04 Mn | - |
| 9 | Bruker | 8.91 Bn | 8.73 Bn | 416.00 Mn | - |
| 10 | 10x Genomics | 8.16 Bn | 7.61 Bn | 112.50 Mn | - |